Related references
Note: Only part of the references are listed.Environmental Factors Associated with Disease Progression after the First Demyelinating Event: Results from the Multi-Center SET Study
Dana Horakova et al.
PLOS ONE (2013)
Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen-DRB1*15
M. Baarnhielm et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Epstein-Barr virus and multiple sclerosis: interaction with HLA
E. Sundqvist et al.
GENES AND IMMUNITY (2012)
CMV Infection Attenuates the Disease Course in a Murine Model of Multiple Sclerosis
Istvan Pirko et al.
PLOS ONE (2012)
Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis
Anna Karin Hedstrom et al.
BRAIN (2011)
Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis
Ellen M. Mowry et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Common viruses associated with lower pediatric multiple sclerosis risk
E. Waubant et al.
NEUROLOGY (2011)
Environmental risk factors in multiple sclerosis
Klaus Lauer
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
Aquaporin 4 antibody positive central nervous system autoimmunity and multiple sclerosis are characterized by a distinct profile of antibodies to herpes viruses
Johann Sellner et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection
Michael J. Cannon et al.
REVIEWS IN MEDICAL VIROLOGY (2010)
Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis
Anna K. Hedstrom et al.
NEUROLOGY (2009)
Clinical features and viral serologies in children with multiple a multinational observational study
Brenda Banwell et al.
LANCET NEUROLOGY (2007)
GenABEL: an R library for genome-wide association analysis
Yurii S. Aulchenko et al.
BIOINFORMATICS (2007)
The human CMV-UL86 peptide 981-1003 shares a crossreactive T-cell epitope with the encephalitogenic MOG peptide 34-56, but lacks the capacity to induce EAE in rhesus monkeys
Herbert P. M. Brok et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Comment on differential usage of Cellular niches by cytomegalovirus versus EBV- and influenza virus-specific CD8(+) T cells
Angelika Schwanninger et al.
JOURNAL OF IMMUNOLOGY (2007)
Differential. usage of cellular niches by cytomegalovirus versus EBV- and influenza virus-specific CD8+ T cells
Ester M. M. van Leeuwen et al.
JOURNAL OF IMMUNOLOGY (2006)
Epstein-Barr virus and multiple sclerosis - Evidence of association from a prospective study with long-term follow-up
Gerald N. DeLorenze et al.
ARCHIVES OF NEUROLOGY (2006)
Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients
R Zivadinov et al.
NEUROLOGICAL RESEARCH (2006)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Calculating measures of biological interaction
T Andersson et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2005)
Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis
LI Levin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8+ T cells
R Vescovini et al.
EXPERIMENTAL GERONTOLOGY (2004)
Herpesvirus-specific CD8 T cell immunity in old age: Cytomegalovirus impairs the response to a coresident EBV infection
N Khan et al.
JOURNAL OF IMMUNOLOGY (2004)
An altered immune response to Epstein-Barr virus in multiple sclerosis -: A prospective study
P Sundström et al.
NEUROLOGY (2004)
Epstein-Barr virus antibodies and risk of multiple sclerosis -: A prospective study
A Ascherio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Association between clinical disease activity and Epstein-Barr virus reactivation in MS
KP Wandinger et al.
NEUROLOGY (2000)
Share Paper
